| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 0.21 | 0.0% | 30.0% |
| Total Income | 0.21 | 0.0% | 30.0% |
| Expenditure | 7.14 | 30.5% | 42.3% |
| PBT | 16.02 | 270.1% | 247.9% |
| Net Profit | 16.02 | 265.1% | 239.7% |
| OPM | — | ||
| NPM | 100.00% | ||
| EPS | 0.36 | 263.6% | 238.5% |
Rallybio Corporation Reports Financial Results for Q3 2025
04 May 2026 · 4 May, 7:52 am
Summary
Rallybio Corporation issued a press release on November 6, 2025, announcing its financial results for the quarter ended September 30, 2025. The press release is furnished as an exhibit to the current report. The information is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Informational and educational content only. Not investment advice.